Community Interventions for Health can support clinicians in advising patients to reduce tobacco use, improve dietary intake and increase physical activity. by Anthony, D, Dyson, P, Lv, J, Thankappan, K, Champgane, B, Matthews, D

“…</p> <h4>Results</h4> <p>Clinicians in the intervention group felt more prepared to advise smoking cessation and improvement of diet. They were more likely to test serum cholesterol and blood pressure, but less likely to take measurements of height, hip, waist and skin-fold thickness. …”

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis by Messina, S, Mariano, R, Geraldes, R, Kim, S-H, Satukijcha, C, Vecchio, D, Chua, YY, Taylor, J, George, N, Cavey, A, Diaz, AR, Reeve, S, Everett, R, De Luca, G, Leite, MI, Kim, HJ, Palace, J

“…</p> <p><strong>Conclusions:</strong> In NMOSD-AQP4-Ab smoking associates with worse disability not through an increased risk of relapses but through poor relapse recovery. As in MS, smoking cessation should be encouraged in NMOSD-AQP4-Ab.…”

Changing strategies in the management of acute myocardial infarction in modern China by Chen, Z, Jiang, L

“…Further improvements, especially with respect to long-term management after MI, will rely not only on better implementation of the many established cost-effective treatments but also on improvements in the medical care system and more active engagement of the medical profession to improve risk factor management, such as smoking cessation. © 2008 World Heart Federation.…”

Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). by Bradley, F, Morgan, S, Smith, H, Mant, D

“…RESULTS: Basic care was provided to nearly all patients; 253 (95.1%, 95% Cl 91.8-97.4) had blood pressure documented after their MI, 216 of 234 patients eligible for aspirin (92.3%; 88.1-95.4) had been recommended treatment, and the provision of advice on smoking cessation was documented for 27 of 33 continuing smokers (81.8%; 64.5-93.0). …”

A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists - The RedPharm study by Farley, A, Tearne, S, Taskila, T, Williams, R, Mackaskill, S, Etter, J, Aveyard, P

“…We assessed uptake and adherence to the programme and smoking cessation four weeks and six months after a quit day and reduction in the three months following programme end and incorporated a qualitative processes assessment. …”

The association between smoking during pregnancy and hospital inpatient costs in childhood. by Petrou, S, Hockley, C, Mehta, Z, Goldacre, M

“…The results of this study should add an economic dimension to the importance of providing smoking cessation services for pregnant women.…”

Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). by Bradley, F, Morgan, S, Smith, H, Mant, D

“…RESULTS: Basic care was provided to nearly all patients; 253 (95.1%, 95% Cl 91.8-97.4) had blood pressure documented after their MI, 216 of 234 patients eligible for aspirin (92.3%; 88.1-95.4) had been recommended treatment, and the provision of advice on smoking cessation was documented for 27 of 33 continuing smokers (81.8%; 64.5-93.0). …”

The genetic landscape of renal complications in type 1 diabetes. by Sandholm, N, Van Zuydam, N, Ahlqvist, E, Juliusdottir, T, Deshmukh, H, Rayner, N, Di Camillo, B, Forsblom, C, Fadista, J, Ziemek, D, Salem, R, Hiraki, L, Pezzolesi, M, Trégouët, D, Dahlström, E, Valo, E, Oskolkov, N, Ladenvall, C, Marcovecchio, M, Cooper, J, Sambo, F, Malovini, A, Manfrini, M, McKnight, A, Lajer, M, Harjutsalo, V, Gordin, D, Parkkonen, M, Tuomilehto, J, Lyssenko, V, McKeigue, P, Rich, S, Brosnan, M, Fauman, E, Bellazzi, R, Rossing, P, Hadjadj, S, Krolewski, A, Paterson, A, Florez, J, Hirschhorn, J, Maxwell, A, Dunger, D, Cobelli, C, Colhoun, H, Groop, L, McCarthy, M, Groop, P

“…We also found genome-wide genetic correlation between diabetic kidney disease and failure at smoking cessation (P=1.1×10(-4)). Pathway analysis implicated ascorbate and aldarate metabolism (P=9.0×10(-6)), and pentose and glucuronate interconversions (P=3.0×10(-6)) in pathogenesis of diabetic kidney disease. …”

Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations. by Spijkerman, A, van der A, D, Nilsson, P, Ardanaz, E, Gavrila, D, Agudo, A, Arriola, L, Balkau, B, Beulens, J, Boeing, H, de Lauzon-Guillain, B, Fagherazzi, G, Feskens, E, Franks, P, Grioni, S, Huerta, J, Kaaks, R, Key, T, Overvad, K, Palli, D, Panico, S, Redondo, M, Rolandsson, O, Roswall, N, Sacerdote, C

“…Smoking may be regarded as a modifiable risk factor for type 2 diabetes, and smoking cessation should be encouraged for diabetes prevention.…”

Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project... by Jolly, K, Bradley, F, Sharp, S, Smith, H, Thompson, S, Kinmonth, A, Mant, D

“…MAIN OUTCOME MEASURES: Serum total cholesterol concentration, blood pressure, distance walked in 6 minutes, confirmed smoking cessation, and body mass index measured at 1 year follow up. …”

Parental nicotine replacement therapy and offspring bronchitis/bronchiolitis and asthma – a nationwide population-based cohort study by Molero, Y, Zetterqvist, J, Lichtenstein, P, Almqvist, C, Ludvigsson, J

“…Nicotine replacement therapy has been shown to increase smoking cessation. However, no prior studies have explored if parental use decreases the risk of bronchitis/bronchiolitis and asthma in the offspring.…”

Lack of attentional retraining effects in cigarette smokers attempting cessation: A proof of concept double-blind randomised controlled trial by Begh, R, Munafò, M, Shiffman, S, Ferguson, S, Nichols, L, Mohammed, M, Holder, R, Sutton, S, Aveyard, P

“…</p> <p><strong>Methods</strong> This was a double-blind randomised controlled trial that took place in UK smoking cessation clinics. Smokers interested in quitting were randomised to five weekly sessions of attentional retraining (N = 60) or placebo training (N = 58) using a modified visual probe task from one week prior to quit day. …”

The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial under... by Price, H, Tucker, L, Griffin, S, Holman, R

“…METHODS/DESIGN: In a 2 x 2 factorial design participants are allocated at random to a personalised 10-year CVD risk estimate or numerical CVD risk factor values (systolic blood pressure, LDL cholesterol and fasting glucose) and, simultaneously, to receive a brief lifestyle advice intervention targeting physical activity, diet and smoking cessation or not. We aim to recruit 200 participants from Oxfordshire primary care practices. …”

21st-century hazards of smoking and benefits of cessation in the United States. by Jha, P, Ramasundarahettige, C, Landsman, V, Rostron, B, Thun, M, Anderson, R, McAfee, T, Peto, R

“…METHODS: We obtained smoking and smoking-cessation histories from 113,752 women and 88,496 men 25 years of age or older who were interviewed between 1997 and 2004 in the U.S. …”

Updating a systematic review - What difference did it make? Case study of nicotine replacement therapy by Stead, L, Lancaster, T, Silagy, C

“…<br/><br/> <b>Methods:</b> We examined the effects of regular updating of a systematic review of nicotine replacement therapy for smoking cessation. We considered two outcomes. First, we assessed the effect of adding new data to meta-analyses, comparing results in 2000 with the results in 1994. …”

Creating a database of internet-based clinical trials to support a public-led research programme: A descriptive analysis by Brice, A, Price, A, Burls, A

“…There is a predominance of interventions addressing core public health challenges including obesity (8.6%), smoking cessation (5.9%), alcohol abuse (7.7%) and physical activity (10.2%); in mental health issues such as depression (10.9%) and anxiety (5.6%); and conditions where self-management (16.6%) or monitoring (8.1%) is a major feature of care. …”

Nicotine replacement therapy decision based on modified intuitionistic fuzzy analytic hierarchy process / Norfazillah Matmali by Matmali, Norfazillah

“…In dealing with this issue, the Nicotine Replacement Therapy (NRT) as a smoking cessation was introduced as part of the program to decrease the population of smokers. …”
Get full text

Relationship between biopsychosocial and spiritual factors with the readiness to quit smoking by Mohd Haazik Mohamed, Nor Aryana Hassan, Muhamad Hairul Nizam Abd Hamid, Fredie Robinson, Ismail Maakip, Peter Voo Su Kiong

“…Questionnaires such as the stages of change readiness and treatment eagerness scale for smoking cessation (SOCRATES-S), Fagerstrom test for nicotine dependence (FTND), depression anxiety stress scale (DASS), the multidimensional scale of perceived social support (MSPSS), and a modified version of functional assessment of chronic illness therapy - spiritual well-being for non-illness (FACITSP-Non-Illness) were used in this study. …”
Get full text
Get full text

Alternative tobacco and nicotine products us and its associated factors among late adolescents in government colleges in Kota Bharu by Yusof, Nurul Azreen

“…While the other factors such as parental and sibling use, perception that ATNP were less harmful and less addictive, reasons for use such as curiosity, less expensive, to aid smoking cessation, variety of flavours and taste as well as refusal skills were not significant. …”
Get full text

Interventions to reduce harm from continued tobacco use. by Lindson-Hawley, N, Hartmann-Boyce, J, Fanshawe, T, Begh, R, Farley, A, Lancaster, T

“…BACKGROUND: Although smoking cessation is currently the only guaranteed way to reduce the harm caused by tobacco smoking, a reasonable secondary tobacco control approach may be to try and reduce the harm from continued tobacco use amongst smokers unable or unwilling to quit. …”